Forehead

Unlocking Beauty: Revolutionary Study by Renowned New York City Facial Surgeon Reveals Game-Changing Advances in Rhinoplasty

Retrieved on: 
Thursday, March 14, 2024
Nose, Anatomy, Forehead, Beauty, FACS, Research, Rhinoplasty, Medical imaging

The study delves into the intricacies of a rhinoplasty technique that transforms the nose by adjusting the procerus muscle.

Key Points: 
  • The study delves into the intricacies of a rhinoplasty technique that transforms the nose by adjusting the procerus muscle.
  • The objective is to understand the anatomy of the procerus muscle using existing anatomic terms and updating its role.
  • This research closely examines how manipulating the procerus influences the nose shape, crucial for determining both nose length and angles.
  • The study concluded that removing part or all of the procerus helps in refining the frontal angle of the nose.

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Retrieved on: 
Monday, March 11, 2024
American Academy of Dermatology, Microbiota, Marketing, FDA, U.S. FDA, Skin, Forehead, Entrepreneurship, Risk, AAD, Safety, GI, Red, Rosacea, Minocycline, Patient, Clinical trial, Erythema, Vagina, Microbiology, American Academy

SCOTTSDALE, Ariz., March 11, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, announces that data from the Phase 1 clinical trial (DFD-29-CD-006) assessing the impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on the microbial flora of healthy adults were presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting that took place March 8-12, 2024, in San Diego, CA. The clinical trial also assessed the safety and tolerability of the treatment. The data were presented by Srinivas Sidgiddi, M.D., Vice President, Research & Development of Journey Medical. DFD-29 is being developed for the treatment of rosacea in collaboration with Dr. Reddy’s Laboratories Ltd.

Key Points: 
  • The clinical trial also assessed the safety and tolerability of the treatment.
  • The data were presented by Srinivas Sidgiddi, M.D., Vice President, Research & Development of Journey Medical.
  • Microbiological samples were collected from the skin (forehead), stool and vagina at multiple timepoints through the study.
  • Additional information on the DFD-29 Phase 1 clinical trial can be found on ClinicalTrials.gov using the identifier NCT05597462 .

JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval

Retrieved on: 
Tuesday, March 5, 2024
Senior, Tenderness, Infection, Dizziness, AbbVie, XC, Lidocaine, Swelling, Exercise, Skin, Pregnancy, History, Cyst, Red, HIV/AIDS, Trial of the century, Allergy, Social media, Incidence, Neck, Dermatology, Aspirin, Pain, Forehead, Stroke, Hyaluronic acid, Pimple, Pigment, Ibuprofen, Scar, Rash, Anaphylaxis, Chin, Learning, Weakness, Safety, Filler (linguistics), DSM-IV codes, Hypoesthesia, Clinical trial, Paratriathlon, Bleeding, Face, Jaw, ABBV, Injection, Bruise, AMI, Inflammation, FDA, TSR, U.S. FDA, Confusion, Risk, Steroid, Patient, Tell, Wound, Gram, HIV, Cheek

IRVINE, Calif., March 5, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of JUVÉDERM® VOLUMA® XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.1 JUVÉDERM® VOLUMA® XC is the first and only hyaluronic acid (HA) dermal filler to receive U.S. FDA approval for the improvement of moderate to severe temple hollowing with results lasting up to 13 months with optimal treatment.*1

Key Points: 
  • *1
    "The approval of JUVÉDERM® VOLUMA® XC to treat temple hollows further demonstrates Allergan Aesthetics commitment to innovation and addressing patient needs," said Carrie Strom, President, Allergan Aesthetics and Senior Vice President, AbbVie.
  • "This is the first U.S. FDA approval of a hyaluronic acid dermal filler for use in the upper face and addresses a real unmet need for patients."
  • The safety of JUVÉDERM® VOLUMA® XC in patients with a history of excessive scarring or pigmentation disorders has not been studied.
  • To report a side effect with any product in the JUVÉDERM® Collection, please call the Allergan® Product Support Department at 1‑877‑345‑5372.

What are ‘multiplication facts’? Why are they essential to your child’s success in maths?

Retrieved on: 
Tuesday, February 13, 2024
Head, Research, Education, Thought, RMIT, Table, Language, Hope, Forehead, Learning, Mathematics, Memory, Child, Probability, Statistics, Student

One of the essential skills students need to master in primary school mathematics are “multiplication facts”. What are they? What are they so important? And how can you help your child master them? What are multiplication facts? Multiplication facts typically describe the answers to multiplication sums up to 10x10.

Key Points: 


One of the essential skills students need to master in primary school mathematics are “multiplication facts”. What are they? What are they so important? And how can you help your child master them?

What are multiplication facts?

  • Multiplication facts typically describe the answers to multiplication sums up to 10x10.
  • You may recall learning multiplication facts in school from a list of times tables.
  • In contrast, we hope today’s students can use their multiplication facts knowledge to quickly see how 15x8 is equivalent to 10x8 plus 5x8.

Maths education has changed

  • In a previous piece, we talked about how mathematics education has changed over the past 30 years.
  • How your child's maths education might be very different from yours

Why are multiplication facts so important?

  • By the end of primary school, it is expected students will know multiplication facts up to 10x10 and can recall the related division fact (for example, 10x9=90, therefore 90÷10=9).
  • Learning multiplication facts is also essential for developing “multiplicative thinking”.
  • So, supporting your child to develop their confidence and proficiency with multiplication is key to their success in high school mathematics.
  • Below are three research-based tips to help support children from Year 2 and beyond to learn their multiplication facts.

1. Discuss strategies

  • One way to help your child’s confidence is to discuss strategies for when they encounter new multiplication facts.
  • For example, once your child has mastered the x2 multiplication facts, you can discuss how 3x6 (3 sixes) can be calculated by doubling 6 (2x6) and adding one more 6.
  • Strategies can be individual: students should be using the strategy that makes the most sense to them.
  • It can also be a great drawing activity where you both have a go at drawing your strategy and then compare.
  • Identifying multiple strategies develops flexible thinking.

2. Help them practise

  • A great game you could play with your children is “multiplication heads up” .
  • Using a deck of cards, your child places a card to their forehead where you can see but they cannot.
  • If it is challenging to organise time to pull out cards, you can make an easier game by simply quizzing your child.

3. Find patterns


Another great activity to do at home is print some multiplication grids and explore patterns with your child.

  • A first start might be to give your child a blank or partially blank multiplication grid which they can practise completing.
  • Then, using coloured pencils, they can colour in patterns they notice.
  • For example, the x6 column is always double the answer in the x3 column.


The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Oakland Zoo Provides Care for Recently Seized Marmoset Monkey

Retrieved on: 
Thursday, February 8, 2024
Malnutrition, Human, ARCAS, Medicine, Social media, Forehead, Housing, Ulna, Zoonosis, Port, Oakland Zoo, Primate, California Department, Keepers, Health, Seizure, CDFW, WCN, Movement, Trauma, SIV, Animal, Behavior, TB, Hospital, Anesthesia, Risk, Research, Pet, Zoo, Rabies, Quarantine, Rehabilitation, SFO, HIV, Music, Female

OAKLAND, Calif., Feb. 8, 2024 /PRNewswire-PRWeb/ -- On January 20th, Oakland Zoo worked with the California Department of Fish and Wildlife (CDFW) and the Wildlife Confiscation Network (WCN) to rescue an illegally owned female marmoset in a seizure of the monkey from a private residence in southern California. The owner was arrested on other charges unrelated to having the female marmoset and was made aware in advance that the animal was to be seized by authorities. Oakland Zoo was contacted after San Diego Zoo and Los Angeles Zoo (other Association of Zoos and Aquariums accredited partners) could not take in the marmoset due to the capacity concerns related to other WCN rescues they were involved with.

Key Points: 
  • Oakland Zoo is caring for a female marmoset named Estrela, an illegally owned pet, after being seized by California Department of Fish and Wildlife officials.
  • Oakland Zoo was contacted after San Diego Zoo and Los Angeles Zoo (other Association of Zoos and Aquariums accredited partners) could not take in the marmoset due to the capacity concerns related to other WCN rescues they were involved with.
  • Estrela will remain in the care of the Oakland Zoo and housed in their Veterinary Hospital until she has completed her quarantine period.
  • For years, animals confiscated by officials at SFO, and the Port of Oakland have been brought to Oakland Zoo for treatment, care, and permanent sanctuary.

InventHelp Inventor Develops Versatile Travel Accessory (DAL-407)

Retrieved on: 
Monday, February 5, 2024
Forehead, Sale, Suite, Sleep, Travel, Head

My design would be easy to store and transport in a purse, backpack, or travel tote.”

Key Points: 
  • My design would be easy to store and transport in a purse, backpack, or travel tote.”
    The patent-pending invention provides a travel accessory that would combine a cushioned headrest together with solitude.
  • The invention features a versatile and portable design that is easy to use so it is ideal for travelers.
  • The original design was submitted to the Dallas sales office of InventHelp.
  • 22-DAL-407, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext.

Human medicines European public assessment report (EPAR): Nuceiva, botulinum toxin type a, Date of authorisation: 27/09/2019, Revision: 6, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Medical Subject Headings, Marketing, INN, Constipation, Infection, Allergy, Forehead, ATC, Antibody, Depression, International, Skin, Injection, Headache, Eyelid, Lambert–Eaton myasthenic syndrome, Language, Ageing, Muscle weakness, Inflammation, Eyebrow, Hypersensitivity, Anxiety, Muscle contraction, Clostridium botulinum, European Medicines Agency, Myasthenia gravis, Acetylcholine, Select, Patient, Safety, Anatomy, GLS, Disorder, IIA, Medical device

Human medicines European public assessment report (EPAR): Nuceiva, botulinum toxin type a, Date of authorisation: 27/09/2019, Revision: 6, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Nuceiva, botulinum toxin type a, Date of authorisation: 27/09/2019, Revision: 6, Status: Authorised

Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression

Retrieved on: 
Monday, December 18, 2023
Risk, Migraine, Zygomatic bone, Grammatical mood, Forehead, Depression, Capital Medical University, Trial of the century, Clinical trial, Behavior, Appetite, Sleep, MDD, Patient, TRD, Pharmaceutical industry

The published results of the study concluded that repeated treatment with Nexalin’s neurostimulation device suggests an acute effect in reducing depressive symptoms in patients with TRD.

Key Points: 
  • The published results of the study concluded that repeated treatment with Nexalin’s neurostimulation device suggests an acute effect in reducing depressive symptoms in patients with TRD.
  • Major depressive disorder (MDD), also known as clinical depression, is a mental health condition that affects mood, behavior, appetite, and sleep.
  • We believe the data provides further evidence of the significant impact of our non-invasive, drug-free device on improving mental healthcare outcomes among patients affected with TRD.
  • No significant adverse effects were reported, which is especially noteworthy given the growing number of patients seeking non-pharmacological treatment options.

California Milk Processor Board Launches New "Get Real Inc." Campaign with Desi Banks and Social Influencers to Encourage Authenticity

Retrieved on: 
Thursday, December 7, 2023
Social Media, Marketing, Advertising, Communications, Food, Beverage, Celebrity, Retail, Entertainment, California Milk Processor Board, Invention, Glass, Johnnycake, Boys & Girls Club, Eating, Social media, G4TV, Emotion, Nutrient, Forehead, HOK, Personality, AI, Virtue, Thought, HBO, Tourism

campaign, recently announced its latest advertising initiative – "Get Real Inc." This campaign, designed to resonate with Californians, features actor and comedian Desi Banks, who joins forces with a crew of social media influencers.

Key Points: 
  • campaign, recently announced its latest advertising initiative – "Get Real Inc." This campaign, designed to resonate with Californians, features actor and comedian Desi Banks, who joins forces with a crew of social media influencers.
  • Together, they present innovative creations aimed at promoting authenticity in a world increasingly dominated by technology and artificiality.
  • Get Real Inc. is positioned as a fictional start-up, with a mission inspired by a glass of real milk, that humorously highlights modern society’s increasing detachment from what’s real.
  • Steve James, Executive Director of the California Milk Processor Board said, “Real milk isn't just a beverage; it's a natural source of essential nutrients, a symbol of authenticity, and a way to savor life's real moments.

Amorepacific receives the CES Innovation Award for fifth consecutive year

Retrieved on: 
Thursday, November 16, 2023
Research, CES, Chin, Beauty, Nose, Multimedia, Algorithm, Amorepacific Corporation, Consumer electronics, Intelligence, Light, Health, Lip, Emotion, Forehead, Riboflavin, 2D, Elasticity, Wellness, Ageing, Diagnosis, Hygiene, Water, R, 3D, Colorimetry, Mouth, AI, Skin, Digital health, Temperature, Cosmetics

SEOUL, South Korea, Nov. 15, 2023 /PRNewswire/ -- Amorepacific's 'Lipcure Beam' technology has been honored with the Consumer Electronics Show 2024 (CES 2024) Innovation Award, marking the company's fifth consecutive win at the influential worldwide tech event.

Key Points: 
  • Based on the diagnostic results, the brush-like cosmetic applicator emits optimally customized visible light to aid in lip care.
  • Developed at the Amorepacific R&I Center, a light-responsive material applied to the lips interact with light emitted from the 'Lipcure Beam', maximizing the response of riboflavin, a natural vitamin.
  • Byung-Fhy Suh, Head of Amorepacific R&I Center, commented, "We are profoundly honored that Amorepacific's renowned strengths in skin biotechnology and our dedicated research and development in customer-centric technology have led to us winning our fifth consecutive CES Innovation Award.
  • Amorepacific's 'Formularity - Instant Active Toner Blending Device' received the CES 2021 Innovation Award in the Health & Wellness category.